Stay updated on INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a small platform update that does not alter the study details or displayed content.
    Difference
    0.0%
    Check dated 2026-07-28T14:40:36.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added external registry identifiers JapicCTI-194983, NMRR-19-1491-48537, jRCT2080224898, and CTR20192589 to the study record. Removed older milestone dates (2026-02-27, 2026-02-26, 2026-02, 2026-05-01) and added new dates (2026-07-13, 2026-06-17, 2026-06, 2026-12-31).
    Difference
    0.2%
    Check dated 2026-07-14T06:53:22.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the page content. This update reflects an updated release of study documents and related UI elements.
    Difference
    0.0%
    Check dated 2026-07-07T00:41:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a small platform update. No study content or data appears to be affected.
    Difference
    0.0%
    Check dated 2026-06-29T17:49:15.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added recruitment status message 'No longer looking for participants' and new user-help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. Formatting changes include updating the header from 'Intervention / Treatment' to 'Intervention/Treatment' and bumping the revision tag to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T08:48:55.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page's Revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the page’s underlying version.
    Difference
    0.0%
    Check dated 2026-06-08T04:13:27.000Z thumbnail image

Stay in the know with updates to INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.